BACKGROUND: Nephropathia epidemica (NE) is a mild form of hemorrhagic fever with renal syndrome caused by Puumala hantavirus. Its long-term prognosis is considered favorable. Some reports suggest, however, that a previous hantavirus infection increases the risk of hypertension. METHODS: We studied 46 previously healthy subjects (26 males and 20 females, mean age of 44 years) who had serologically confirmed NE three to seven years previously, and 38 healthy, seronegative controls (22 males and 16 females, mean age of 44 years). Ambulatory blood pressure (ABP) was monitored. Glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were determined by 51CrEDTA and 131I-hippurate clearances, respectively. The filtration fraction (FF) was calculated. Quantitative 24-hour urinary protein excretion (UprotE) and timed overnight urinary excretion of alpha1-microglobulin were measured. RESULTS: The NE patients had a higher mean ambulatory systolic BP than the controls (123 +/- 13 vs. 117 +/- 9 mm Hg, P = 0. 008). GFR and FF were increased in patients compared with controls (GFR, 120 +/- 20 vs. 109 +/- 14 mL/min/1.73 m2, P = 0.006; FF, 19 +/- 3 vs. 18 +/- 3%, P = 0.030), but ERPF did not differ between the groups. The patients also had higher UPE than the controls (median 0. 18 g/day, range 0.12 to 0.38 vs. median 0.14 g/day, range 0.09 to 0. 24, P < 0.001, respectively). The overnight urinary excretion rate of alpha1-microglobulin exceeded 7 microg/min in nine patients. CONCLUSION: Three to seven years after NE, the patients had higher GFR and FF, more proteinuria, and higher ambulatory systolic BP compared with the healthy controls. NE may thus cause mild renal lesions and alterations in BP in some patients.
BACKGROUND:Nephropathia epidemica (NE) is a mild form of hemorrhagic fever with renal syndrome caused by Puumala hantavirus. Its long-term prognosis is considered favorable. Some reports suggest, however, that a previous hantavirus infection increases the risk of hypertension. METHODS: We studied 46 previously healthy subjects (26 males and 20 females, mean age of 44 years) who had serologically confirmed NE three to seven years previously, and 38 healthy, seronegative controls (22 males and 16 females, mean age of 44 years). Ambulatory blood pressure (ABP) was monitored. Glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were determined by 51CrEDTA and 131I-hippurate clearances, respectively. The filtration fraction (FF) was calculated. Quantitative 24-hour urinary protein excretion (UprotE) and timed overnight urinary excretion of alpha1-microglobulin were measured. RESULTS: The NE patients had a higher mean ambulatory systolic BP than the controls (123 +/- 13 vs. 117 +/- 9 mm Hg, P = 0. 008). GFR and FF were increased in patients compared with controls (GFR, 120 +/- 20 vs. 109 +/- 14 mL/min/1.73 m2, P = 0.006; FF, 19 +/- 3 vs. 18 +/- 3%, P = 0.030), but ERPF did not differ between the groups. The patients also had higher UPE than the controls (median 0. 18 g/day, range 0.12 to 0.38 vs. median 0.14 g/day, range 0.09 to 0. 24, P < 0.001, respectively). The overnight urinary excretion rate of alpha1-microglobulin exceeded 7 microg/min in nine patients. CONCLUSION: Three to seven years after NE, the patients had higher GFR and FF, more proteinuria, and higher ambulatory systolic BP compared with the healthy controls. NE may thus cause mild renal lesions and alterations in BP in some patients.
Authors: S F Khaiboullina; E V Martynova; Z L Khamidullina; E V Lapteva; I V Nikolaeva; V V Anokhin; V C Lombardi; A A Rizvanov Journal: Eur J Clin Microbiol Infect Dis Date: 2014-06-19 Impact factor: 3.267
Authors: Steven A Pergam; Darren W Schmidt; Robert A Nofchissey; William C Hunt; Antonia H Harford; Diane E Goade Journal: Am J Trop Med Hyg Date: 2009-02 Impact factor: 2.345
Authors: Joerg Latus; Matthias Schwab; Evelina Tacconelli; Friedrich-Michael Pieper; Daniel Wegener; Juergen Dippon; Simon Müller; David Zakim; Stephan Segerer; Daniel Kitterer; Martin Priwitzer; Barbara Mezger; Birgit Walter-Frank; Angela Corea; Albrecht Wiedenmann; Stefan Brockmann; Christoph Pöhlmann; M Dominik Alscher; Niko Braun Journal: Emerg Infect Dis Date: 2015-01 Impact factor: 6.883
Authors: Ekaterina V Martynova; Aygul H Valiullina; Oleg A Gusev; Yuriy N Davidyuk; Ekaterina E Garanina; Venera G Shakirova; Ilsiyar Khaertynova; Vladimir A Anokhin; Albert A Rizvanov; Svetlana F Khaiboullina Journal: J Immunol Res Date: 2016-12-05 Impact factor: 4.818
Authors: Svetlana F Khaiboullina; Silvana Levis; Sergey P Morzunov; Ekaterina V Martynova; Vladimir A Anokhin; Oleg A Gusev; Stephen C St Jeor; Vincent C Lombardi; Albert A Rizvanov Journal: Front Immunol Date: 2017-05-18 Impact factor: 7.561